Xiaolin Wang - Dec 17, 2021 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
EVP, Clinical Development
Signature
/s/ Jack Anders, as Attorney-in-fact for Xiaolin Wang
Stock symbol
RVMD
Transactions as of
Dec 17, 2021
Transactions value $
-$6,273
Form type
4
Date filed
12/21/2021, 03:33 PM
Previous filing
Sep 21, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Sale -$6.27K -257 -2.11% $24.41 11.9K Dec 17, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
F2 Includes 9,100 RSUs.

Remarks:

EVP, Clinical Development